Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy

Human Pathology

Volumn 43, Issue 7, 2012, Pages 1003-1011

  Cimino Mathews, Ashley ^a   Hicks, Jessica L ^a   Illei, Peter B ^a   Halushka, Marc K ^a   Fetting, John H ^a   De Marzo, Angelo M ^a   Park, Ben Ho ^a   Argani, Pedram ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Androgen receptor; Breast carcinoma; Metastasis

Indexed keywords

ANDROGEN RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ANTIANDROGEN THERAPY; ARTICLE; AUTOPSY; BREAST CARCINOMA; BREAST METASTASIS; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; TISSUE MICROARRAY;

ADULT; AGED; BRAIN NEOPLASMS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; OVARIAN NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 84862551382     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.08.007     Document Type: Article

References (22)

1. Moinfar F, Okcu M, Tsybrovskyy O, et al. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. Cancer 2003;98:703-11.
2. Park S, Koo J, Park HS, et al. Expression of androgen receptors in primary breast cancer. Ann Oncol 2010;21:488-92.
3. Neimeier LA, Dabbs DJ, Beriwal S, Striebel JM, Bhargava R. Androgen receptor in breast cancer: expression in estrogen receptor - positive tumors and in estrogen receptor - negative tumors with apocrine differentiation. Mod Pathol 2010;23:205-12.
4. Agoff SN, Swanson PE, Linden H, Hawes SE, Lawton TJ. Androgen receptor expression in estrogen receptor - negative breast cancer. Immunohistochemical, clinical, and prognostic associations. Am J Clin Pathol 2003;120:725-31.
5. Hanley K, Wang J, Bourne P, et al. Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast. HUM PATHOL 2008;39:386-92.
6. Micello D, Marando A, Sahnane N, Riva C, Capella C, Sessa F. Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers. Virchows Arch 2010;457:467-76.
7. Gucalp A, Traina TA. Triple-negative breast cancer: role of the androgen receptor. Cancer J 2010;16:62-5.
8. Nahleh Z. Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory. Future Oncol 2008;4:15-21.
9. Schippinger W, Regitnig P, Dandachi N, et al. Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer. Virchows Arch 2006;449:24-30.
10. Wu JM, Fackler MJ, Halushka MK, et al. Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res 2008;14:1938-46.
11. Subhawong AP, Subhawong T, Nassar H, et al. Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically. Am J Surg Pathol 2009;33:163-75.
12. Subhawong AP, Nassar H, Halushka MK, et al. Heterogeneity of Bcl-2 expression in metastatic breast carcinoma. Mod Pathol 2010;23: 1089-96.
13. Manni A, Arafah B, Pearson OH. Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy. Cancer 1980;46(12 Suppl):2838-41.
14. Osborne CK, Yochmowitz MG, Knight III WA, McGuire WL. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 1980;46(12 Suppl):2884-8.
15. Dowsett M, Dunbier AK. Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer. Clin Cancer Res 2008;14:8019-26.
16. Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer 2003:97545-53.
17. Leal C, Henrique R, Monteiro P, et al. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. HUM PATHOL 2001;32:487-93.
18. Riva C, Dainese E, Caprara G, et al. Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma. Virchows Arch 2005;447:695-700.
19. Lodde M, Lacombe L, Fradet Y. Salvage therapy with bicalutamide 150 mg in nonmetastatic castration-resistant prostate cancer. Urology 2010;76:1189-93.
20. Gown AM. Current issues in ER and HER2 testing by IHC in breast cancer. Mod Pathol 2008;21(Suppl 2):S8-15.
21. Cimino A, Halushka M, Illei P, et al. Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases. Breast Cancer Res Treat 2010;123:701-8.
22. Singhi AD, Jenkins RB, Lin F, et al. MYC gene amplification in breast cancer metastases relative to matched primary tumors. Mod Pathol 2010;23:73A.